One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Nanoparticle-based pazopanib shows promise in OA
Rebecca Kelsey
doi : 10.1038/s41584-024-01104-w
Volume 20 Issue 5, May 2024
All fibroblasts are equal, but some are more equal than others
Chrissy Bolton & Adam P. Croft
A nosology of immune diseases from deep immunophenotyping
Michael F. McDermott
Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis
Margaret H. Chang, Robert C. Fuhlbrigge & Peter A. Nigrovic
Molecular biomarker approaches to prevention of post-traumatic osteoarthritis
Virginia Byers Kraus & Ming-Feng Hsueh
Low-frequency and rare genetic variants associated with rheumatoid arthritis risk
Vanessa L. Kronzer, Jeffrey A. Sparks, Soumya Raychaudhuri & James R. Cerhan
Genetically transitional disease: conceptual understanding and applicability to rheumatic disease
Timothy B. Niewold, Ivona Aksentijevich, Peter D. Gorevic, Greg Gibson & Qingping Yao
Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups
Margherita Giannini, Léa Debrut, Benoit Nespola, Michel Velten, Bernard Geny, Jean Sibilia & Alain Meyer
Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups
Thomas Khoo, James B. Lilleker, Bernard Yu-Hor Thong, Valérie Leclair, Janine A. Lamb & Hector Chinoy
Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative
Alexander G. S. Oldroyd, Jeffrey P. Callen, Hector Chinoy, Lorinda Chung, David Fiorentino, Patrick Gordon, Pedro M. Machado, Neil McHugh, Albert Selva-O’Callaghan, Jens Schmidt, Sarah L. Tansley, Ruth Ann Vleugels, Victoria P. Werth, International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group & Rohit Aggarwal
Author Correction: Proposals for the rheumatological use of JAK inhibitors
Francesco Ciccia & Roberto Caporali
